Add BrightSurf on Google Email

Breakthrough: Natural bacteria compound offers safe skin lightening

Researchers at Tokyo University of Science discovered a natural tyrosinase inhibitor from Corynebacterium tuberculostearicum that inhibits melanin synthesis and provides an alternative to toxic hydroquinone-based products. The compound, cyclo(L-Pro-L-Tyr), exhibits low toxicity and potential benefits for hyperpigmentation treatment.

SourceTokyo University of Science·JournalInternational Journal of Molecular Sciences·TypeExperimental study·DateAug 5, 2024

An adjuvant made in yeast could lower vaccine cost and boost availability

Researchers at the University of California, Berkeley, have successfully produced the QS-21 adjuvant in yeast, which is currently extracted from tree bark. The production process is cheaper and more environmentally friendly than traditional methods, making it a promising solution for lowering vaccine costs and increasing availability.

SourceUniversity of California - Berkeley·JournalNature·TypeExperimental study·DateMay 8, 2024

Marine algae implants could boost crop yields

Researchers have discovered the gene responsible for producing a unique type of chlorophyll in marine algae. This breakthrough could lead to improved crop yields on less land, making it a key step towards achieving a more sustainable food supply. The study also demonstrated that a land plant can produce this specific type of chlorophyll.

SourceUniversity of California - Riverside·JournalCurrent Biology·DateMar 6, 2024

A high-quality Bougainvillea genome helps to explore the evolutionary history of species and pigment biosynthetic pathway

The high-quality Bougainvillea genome assembly provides new insights into the species' evolutionary history, genetic duplication events, and pigment biosynthetic pathways. The study's findings suggest that bract coloration requires high levels of expression for the betacyanin biosynthetic pathway.

SourceNanjing Agricultural University The Academy of Science·JournalHorticulture Research·TypeExperimental study·DateOct 22, 2023

Nature is inventive - the same substance is produced differently by plants

Researchers have found that benzoxazinoids, a special plant defense compound, evolved independently in distantly related plant families. The study used two species, golden dead-nettle and zebra plant, to elucidate the metabolic pathway of these compounds, revealing unexpected diversity in enzymes performing the same reactions.

SourceMax Planck Institute for Chemical Ecology·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateOct 9, 2023

New enzyme could aid anticancer drug development

A new enzyme, CtdY, has been identified that can break an amide bond, a fundamental type of bond found in proteins. This discovery holds significant promise for the pharmaceutical industry, as it could enable the creation of new anticancer drugs and improve treatment outcomes.

SourceRice University·JournalJournal of the American Chemical Society·TypeExperimental study·DateJun 27, 2023

Study deciphers the biosynthetic pathway of the antidepressant orcinol glucoside from the plant Curculigo orchioides and engineers the production of orcinol glucoside in the biotech-friendly yeast Yarrowia lipolytica, with yields over 6,400-fold higher th

Researchers have deciphered the biosynthetic pathway of orcinol glucoside from Curculigo orchioides and successfully engineered its production in Yarrowia lipolytica. The resulting yields are significantly higher, exceeding 6,400-fold that of natural plant extraction.

SourcePLOS·JournalPLOS Biology·DateJun 6, 2023

Microbes powered by electricity

Researchers at Leibniz-HKI have confirmed experimentally that bacteria use electrons from hydrogen to produce organic compounds. This breakthrough could make microbial electrosynthesis (MES) a commercially viable technology, producing ethanol and other fuels while storing excess electricity. The study optimized the process for high yie...

Comprehensive analysis of single plant cells provides new insights into natural product biosynthesis

Researchers used single-cell multi-omics to study specialized cell types involved in producing medically relevant plant compounds. The analyses revealed that three distinct cell types are organized in a specific biosynthetic pathway for vinblastine, a key alkaloid compound with anti-cancer properties.

SourceMax Planck Institute for Chemical Ecology·JournalNature Chemical Biology·TypeExperimental study·DateMay 15, 2023

Revealing biochemical “rings of power”

Researchers at Max-Planck Institute for Terrestrial Microbiology have deciphered the biosynthesis of benzobactins, a class of natural compounds with special biological activity. The study reveals that these compounds are widespread in diverse bacteria and could be excellent candidates for future drug therapy.

SourceMax-Planck-Gesellschaft·JournalAngewandte Chemie·TypeMeta-analysis·DateNov 18, 2022

New insights into how serotonin regulates behavior

New research by Frank Schroeder's team reveals two parallel biosynthetic pathways for serotonin production in C. elegans, challenging the long-held assumption that serotonin is made and quickly broken down. The findings suggest new therapeutic targets for treating anxiety, depression, and eating disorders.

SourceBoyce Thompson Institute·JournalNature Chemical Biology·TypeExperimental study·DateOct 13, 2022

Interactive map of metabolical synthesis of chemicals​

Researchers have developed an interactive metabolic map of bio-based chemicals, providing a versatile tool for easy assessment and optimization of synthetic pathways. The map enables exploration and analysis of complex networks of biological and/or chemical reactions, facilitating the design and production of desired chemicals.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalTrends in Biotechnology·TypeObservational study·DateAug 11, 2022

Melioidosis: New target to combat a dangerous bacterial infection

A new therapeutic target for melioidosis has been identified by researchers at the Leibniz Institute for Natural Product Research and Infection Biology. The enzyme BurG synthesizes a toxic molecule central to infection, and inhibiting it could make bacteria less virulent.

Plant scientists find recipe for anti-cancer compound in herbs

Researchers at Purdue University have identified a new pathway for producing the anti-cancer compound thymohydroquinone, found in plants like thyme and oregano. By understanding this process, plant scientists can engineer plants to produce higher levels of beneficial compounds or synthesize them in microorganisms.

SourcePurdue University·JournalProceedings of the National Academy of Sciences·DateDec 20, 2021

Bacterial toxins made in the gut

Austrian scientists identify critical enterotoxin tilivalline and its potent metabolite tilimycin, produced by penicillin-resistant bacteria. The discovery provides insights into antibiotic side reactions and potential new approaches for producing anticancer drugs.

SourceWiley·JournalAngewandte Chemie International Edition·DateOct 25, 2017

Bioengineering efficient antibiotic biosynthesis in E. coli

Researchers used bioassay-guided evolution to identify more efficient antibiotic-producing mutants in Escherichia coli, reconstituting the biosynthetic pathways of sugars to yield a new antibiotic. This approach opens doors for harnessing genetics to investigate polyketide synthases and biosynthetic engineering.

SourcePLOS·JournalPLOS Biology·DateFeb 5, 2007

Fatty acid pathway, glucose combine to produce triacetic acid lactone

Researchers have successfully produced triacetic acid lactone (TAL) by combining the fatty acid biosynthetic pathway with glucose, offering an alternative to traditional methods using petroleum or chemicals. This breakthrough enables the production of TATB, a more stable and sensitive explosive than TNT.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalJournal of the American Chemical Society·DateApr 1, 2004